Search Results

decision-making. “Gastric cancer is a leading cause of cancer-related deaths globally, and Lilly is deeply committed to patients with this aggressive disease,” said Maura Dickler, MD, Vice President of Late Phase Development, Lilly Oncology. “We are proud

, switching to a different HER2-directed therapy, as disease progresses. As long as the patient appears to be benefitting, and there are reasonable expectations, we continue systemic therapy, with shared decision-making,” he commented. A recent addition to the

approach for management, which can provide challenges for optimal coordination. These projects will explore opportunities to leverage technology in order to improve patient outcomes and quality of life through supportive services, shared decision-making

The awardees responded to an RFP from NCCN ORP and Pfizer IGLC seeking concepts for initiatives focusing on the following areas where gaps in care currently exist: Provider education and provider/patient treatment shared decision-making Adoption

frequently updated medical guidelines in any discipline; they should also be the most accessible. The convenience of Flatiron Assist can give doctors more time to engage in shared decision making in order to determine which guideline-concordant treatment plan

order to identify perceived competency gaps ( Figure 1 ). Interestingly, the smallest perceived gaps in ability were related to engaging the patient in shared decision-making for therapy selection and communicating disease status or updating patients on

and responsive clinical interactions and shared decision-making, a core component of person-centered care. 15 Research indicates that routine SFD improves quality of care, such as patient–provider interactions, 16 and symptom management 17 ; however

to improve shared decision-making between patients and physicians. However, there is limited research on the relevancies of the numerous available PROs to patients with PDAC and whether these align with what their physicians believe are patient

cancer survivors who have in-field NMSC with low-risk histologic and clinical features, dermatologic therapy options with lower costs and risks should be considered in the shared decision-making process. Limitations of this study include a study

screening rates are suboptimal, with at least one-third of eligible patients having never been screened, the USPSTF asserts that the “best screening test is the one that gets done.” Shared decision-making is an approach to choosing the “best” and preferred